Can metabolic dysfunction, inflammatory signaling, and HPA-axis dysregulation reinforce each other bidirectionally?

Physiological stress, metabolic overload, and immune activation do not act in isolation; instead, they operate within a highly integrated, tripartite network.

Mechanistic feedback loops

• Metabolic-Inflammatory Axis: Metabolic dysfunction—driven by visceral adiposity, hyperglycemia, and dyslipidemia—stimulates the release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). This state is further accelerated by metabolic endotoxemia, where low-grade circulating lipopolysaccharides (LPS) activate TLR4 receptors on innate immune cells. Conversely, persistent TNF-α and IL-6 impair intracellular insulin signaling pathways, directly driving insulin resistance and worsening metabolic dysfunction.
• Inflammatory-HPA Axis: Elevated pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) stimulate the hypothalamic-pituitary-adrenal (HPA) axis, promoting the release of corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH). Although cortisol is inherently anti-inflammatory, chronic cytokine exposure alters glucocorticoid receptor (GR) phosphorylation and upregulates the inactive GRβ isoform. This induces glucocorticoid receptor resistance, weakening cortisol’s negative feedback control and enabling persistent systemic inflammation.
• HPA-Metabolic Axis: Sustained HPA-axis hyperactivity and cortisol excess promote profound metabolic shifts, including visceral adiposity, hepatic gluconeogenesis, and dyslipidemia. These metabolic perturbations in turn feed back to sustain low-grade systemic inflammation and further impair HPA-axis sensitivity.

Bottom line

• Metabolic dysfunction, inflammatory signaling, and HPA-axis dysregulation represent a bidirectional, feed-forward pathological loop. Disruption in any single node acts as a clinical catalyst, reinforcing and accelerating systemic deterioration across all three systems.